|
Index of reports
> Cases with Anxiety (59)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prohance (Gadoteridol) where reactions include anxiety. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 59 Next >>
Possible Prohance side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Prohance side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Possible Prohance side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-27
Patient: female
Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Possible Prohance side effects in 79 year old female
Reported by a physician from United States on 2012-07-20
Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Dosage: dose reported as eight 20ml vials (160ml)
Start date: 2005-09-20
End date: 2005-09-20
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Multihance
Indication: Angiogram
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Gadolinium Zeolite
Start date: 2005-08-16
End date: 2005-08-16
Omniscan
Dosage: route reported as ^first via distal port and then via the proximal port^
Indication: Angiogram
Start date: 2003-12-04
End date: 2003-12-04
Optimark
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-08-16
End date: 2005-08-16
Optimark
Indication: Angiogram
Gadolinium Zeolite
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2001-03-05
End date: 2001-03-05
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-05-23
End date: 2003-05-23
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: dose reported as ^11^ 20ml vials
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar
Possible Prohance side effects in 51 year old female
Reported by a lawyer from United States on 2012-07-09
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Fistulogram
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Optimark
Indication: Venogram
Multihance
Indication: Venogram
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Prohance
Indication: Venogram
Prohance
Indication: Fistulogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis Device Insertion
Omniscan
Indication: Fistulogram
Optimark
Indication: Fistulogram
Omniscan
Indication: Venogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl
Possible Prohance side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female
Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Omniscan
Indication: Angiogram
Multihance
Indication: Angiogram
Prohance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Possible Prohance side effects in 58 year old female
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, unk
Indication: Imaging Procedure
Start date: 2003-12-20
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-05-26
End date: 2005-05-26
Prohance
Indication: Imaging Procedure
Magnevist
Dosage: 15 ml, unk
Indication: Angiogram
Start date: 2006-05-30
Omniscan
Indication: Imaging Procedure
Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps
Possible Prohance side effects in 51 year old female
Reported by a lawyer from United States on 2012-05-31
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Omniscan
Indication: Venogram
Optimark
Indication: Venogram
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Indication: Dialysis Device Insertion
Multihance
Indication: Fistulogram
Prohance
Indication: Fistulogram
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Fistulogram
Prohance
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Fistulogram
Multihance
Indication: Venogram
Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate
Possible Prohance side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax
Possible Prohance side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient: female
Reactions: Anxiety, Emotional Distress, Pain, Injury, Fibrosis, Nephrogenic Systemic Fibrosis, Deformity, Disability
Drug(s) suspected as cause:
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Magnevist
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Indication: Angiogram
Possible Prohance side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril
Possible Prohance side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: 64 year old male
Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Skin Lesion, Injury, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Omniscan
Start date: 2003-02-27
End date: 2003-02-27
Magnevist
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Magnevist
Start date: 2003-02-27
End date: 2003-02-27
Prohance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Multihance
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Lanoxin; Coumadin; Nitroglycerin; Metoprolol Tartrate
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Erythema, Upper Extremity Mass, Joint Stiffness, Muscle Fatigue, Proteinuria, Oedema Peripheral, Renal Cortical Necrosis, Pain in Extremity, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Stress, Emotional Distress, Rash Erythematous, Scar, Soft Tissue Disorder, Pain, Skin Hyperpigmentation, Myosclerosis, Skin Discolouration, Joint Range of Motion Decreased, Oedema, Musculoskeletal Stiffness, Injury, Renal Failure Acute, Musculoskeletal Pain, Rash Papular, Skin Disorder, Renal Failure Chronic, Burning Sensation, Anxiety, Dysstasia, Limb Discomfort, Arthralgia, Renal Tubular Necrosis
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-10-01
Magnevist
Dosage: daily dose 20 ml
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2007-09-05
End date: 2007-09-05
Optimark
Multihance
Magnevist
Dosage: unk
Start date: 2005-05-26
Omniscan
Magnevist
Dosage: unk
Start date: 2004-10-07
Omnipaque 140
Dosage: 150 ml, unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-09-30
End date: 2004-09-30
Hypaque-M [meglumine Amidotrizoate]
Dosage: unk
Administration route: Oral
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-06
End date: 2004-10-06
Prohance
Magnevist
Dosage: unk
Start date: 2005-05-09
Magnevist
Dosage: unk
Start date: 2004-11-18
Magnevist
Dosage: unk
Start date: 2005-05-23
Other drugs received by patient: Cytoxan; Xanax; Sensipar; Ferrous Sulfate TAB; Contrast Media; Immune Globulin NOS; Gabapentin; Valcyte; Contrast Media; Prednisone; Lasix; Marijuana; Midodrine Hydrochloride; Lisinopril; Aspirin; Norvasc; Cyclobenzaprine; Calcium +vit D; Coumadin; Contrast Media; Lopressor; Epogen; Cellcept; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Gengraf; Renagel
Possible Prohance side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 31 year old female, weighing 59.8 kg (131.6 pounds)
Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Muscle Spasticity, Joint Stiffness, Myalgia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, Muscle Contracture, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Stress, Skin Tightness, Finger Deformity, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk
Indication: Angiogram
Start date: 2003-01-10
End date: 2003-01-10
Prohance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2007-01-18
End date: 2007-01-18
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-22
End date: 2003-09-22
Other drugs received by patient: Amlodipine Besylate; Accupril; Ibuprofen; Renagel; Cardura; Depakote; Amiodarone HCL; Elavil; Pravastatin; Labetalol HCL; Phenytoin; Aspirin; Metoprolol Tartrate; Morphine; Plendil; Lovenox; Methadone HCL; Lidocaine; Vitamin K TAB; Clonidine; Heparin; Lamictal; Folic Acid; Enoxaparin; Promethazine; Norvasc; Cardizem; Coumadin; Prednisone TAB; Diazepam; Dilantin; Vicodin; Xanax
Possible Prohance side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Skin Lesion, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Muscular Weakness, Hypoaesthesia, DRY Skin, Skin Hypertrophy, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Plaque, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk unk, once
Indication: Renal Scan
Start date: 2005-08-25
End date: 2005-08-25
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Other drugs received by patient: Pravachol; Sodium Citrate; Kayexalate; Oxycodone HCL; Aspirin; Prednisone; Calcitonin Salmon; Zaroxolyn; MS Contin; Lexapro; Lisinopril; Coumadin; Pentamidine; Compazine; Spiriva; Ativan; Norvasc; Lasix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Flagyl; Calcitriol; Labetalol HCL; Phoslo; Normodyne; Lopressor; Thiamine; Cytoxan; Wellbutrin; Viagra; Heparin; Trazodone HCL; Protonix; Darbepoetin Alfa; Fosamax; Folic Acid; Albuterol; Acetaminophen; Magnesium Oxide; Mirapex
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Soft Tissue Disorder, Pain, Skin Hyperpigmentation, Upper Extremity Mass, Erythema, Joint Stiffness, Myosclerosis, Muscle Fatigue, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Proteinuria, Oedema, Musculoskeletal Stiffness, Injury, Renal Failure Acute, Renal Cortical Necrosis, Pain in Extremity, Musculoskeletal Pain, Rash Papular, Skin Disorder, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, Stress, Renal Failure Chronic, Emotional Distress, Anxiety, Burning Sensation, Limb Discomfort, Dysstasia, Arthralgia, Rash Erythematous, Renal Tubular Necrosis, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Start date: 2005-05-23
Magnevist
Dosage: daily dose 20 ml
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2007-09-05
End date: 2007-09-05
Magnevist
Dosage: unk
Start date: 2004-10-07
Omnipaque 140
Dosage: 150 ml, unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-09-30
End date: 2004-09-30
Omniscan
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-10-01
Hypaque-M [meglumine Amidotrizoate]
Dosage: unk
Administration route: Oral
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-06
End date: 2004-10-06
Magnevist
Dosage: unk
Start date: 2005-05-09
Prohance
Magnevist
Dosage: unk
Start date: 2004-11-18
Optimark
Magnevist
Dosage: unk
Start date: 2005-05-26
Multihance
Other drugs received by patient: Immune Globulin NOS; Lopressor; Epogen; Midodrine Hydrochloride; Cytoxan; Iron; Gengraf; Xanax; Calcium +vit D; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Valcyte; Coumadin; Contrast Media; Renagel; Ferrous Sulfate TAB; Lisinopril; Norvasc; Prednisone; Marijuana; Cyclobenzaprine; Gabapentin; Lasix; Sensipar; Contrast Media; Contrast Media; Mycophenolate Mofetil (Cellcept)
Possible Prohance side effects in 34 year old male
Reported by a lawyer from United States on 2012-04-30
Patient: 34 year old male
Reactions: Pain, Joint Contracture, Skin Hyperpigmentation, Joint Range of Motion Decreased, Fibrosis, Depression, Muscular Weakness, Skin Induration, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Skin Hypertrophy, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Insomnia, Gait Disturbance
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-01-11
End date: 1999-01-11
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Dosage: 17 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-15
End date: 2006-08-15
Other drugs received by patient: Oxycodone HCL; Venlafaxine; Nephrox [aluminium Hydroxide]; Calcium Acetate; Lisinopril; Coreg; Metoprolol Tartrate; Sensipar; Nifedipine; Lactulose; Aspirin; Rena-Vite; Accupril; Coumadin; Omeprazole; Fosrenol; EPO; Alprazolam; Norvasc; Chromagen [ascorbic Acid,cyanocobalamin,ferrous Fumarate,folic ACI; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]
Possible Prohance side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30
Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-04-25
End date: 2006-04-25
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Start date: 2006-05-21
End date: 2006-05-21
Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo
Possible Prohance side effects in 64 year old male
Reported by a lawyer from United States on 2012-04-19
Patient: 64 year old male
Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Anxiety, Emotional Distress, Skin Lesion, Injury, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Magnevist
Start date: 2003-02-27
End date: 2003-02-27
Multihance
Indication: Product Used FOR Unknown Indication
Magnevist
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Omniscan
Start date: 2003-02-27
End date: 2003-02-27
Prohance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nitroglycerin; Lanoxin; Coumadin; Metoprolol Tartrate
Possible Prohance side effects in 51 year old female
Reported by a lawyer from United States on 2012-04-12
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Joint Range of Motion Decreased, Skin Discolouration, Dermatitis, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Hypertrophy, Sclerodactylia, Skin Tightness, Anxiety, Emotional Distress, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Optimark
Indication: Fistulogram
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Omniscan
Indication: Fistulogram
Optimark
Indication: Venogram
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Prohance
Indication: Fistulogram
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Prohance
Indication: Venogram
Multihance
Indication: Venogram
Omniscan
Indication: Venogram
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Fistulogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Atenolol; Allopurinol; Acetaminophen; Calcitriol; Nitroglycerin; Omeprazole; Atenolol; Acetaminophen; Acetaminophen; Loperamide; Tramadol HCL; Coumadin; Renagel; Nifedipine; Vitamin B12; Immune Globulin NOS; Acetaminophen; Fosrenol; Cardizem; Corticosteroids; Protonix; Renagel; Nephro-Vite [vitamins Nos]; Allopurinol; Acetaminophen; Benadryl; Benadryl; Calcium Carbonate; Reglan; Amiodarone HCL; Vicodin; Phoslo; Plendil; Ureacin; Prednisone TAB; Levothroid; Calcium Carbonate; Epogen; Procardia XL; Pravachol; Prilosec; Sensipar; Cyclosporine; Imodium; Benadryl; Benadryl; Pravastatin; Levothroid; Coumadin; Immune Globulin NOS; Acetaminophen; Benadryl; Coumadin; Protonix; Epoetin NOS; Sensipar; Immune Globulin NOS; Immune Globulin NOS; Immune Globulin NOS; Metoclopramide; PEG-3350 and Electrolytes; Metoprolol Tartrate
Possible Prohance side effects in 51 year old female
Reported by a consumer/non-health professional from United States on 2012-04-12
Patient: 51 year old female, weighing 94.0 kg (206.8 pounds)
Reactions: Pain, Joint Contracture, Muscle Tightness, Joint Stiffness, Anhedonia, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Depression, Dyspnoea, Pain in Extremity, Muscle Contracture, Muscular Weakness, Skin Disorder, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Anxiety, Joint Swelling, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Hypoaesthesia
Omniscan
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2002-04-03
End date: 2002-04-03
Prohance
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Other drugs received by patient: Epogen; Iron [iron]; Antibiotics; Warfarin Sodium; Calcium Carbonate; Procrit; Coumadin; Evista; Renagel; Renal [vitamins Nos]; Nexium; Lipitor; Sensipar; Aspirin
Possible Prohance side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-11
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Rash, Nephrogenic Systemic Fibrosis, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Immobile, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Gadolinium IN Unspecified Drug
Indication: Angiogram
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Asthenia
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Lyrica; Tamsulosin HCL; Dexamethasone; Warfarin Sodium; Silodosin; Amiodarone HCL; Norvasc; Actonel; Triamteren HCT; Hydralazine HCL; Iron Sulfatethiamin Compound TAB; Metoprolol Tartrate; Benicar; Omeprazole; Coreg; Metformin HCL; Simvastatin; Potassium
Possible Prohance side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-11
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, General Physical Health Deterioration, Skin Disorder, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Mobility Decreased, Immobile
Drug(s) suspected as cause:
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Magnevist
Indication: Asthenia
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Gadolinium IN Unspecified Drug
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Metoprolol Tartrate; Lyrica; Dexamethasone; Actonel; Triamteren HCT; Tamsulosin HCL; Omeprazole; Simvastatin; Amiodarone HCL; Iron Sulfatethiamin Compound TAB; Benicar; Norvasc; Hydralazine HCL; Warfarin Sodium; Metformin HCL; Silodosin; Coreg; Potassium
Possible Prohance side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11
Patient: 61 year old male, weighing 160.9 kg (354.0 pounds)
Reactions: Thrombosis, Visual Acuity Reduced, Skin Hyperpigmentation, Hyperhidrosis, Dermatitis, Oedema Peripheral, Back Pain, Pain in Extremity, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Hypoaesthesia, Deformity, Tremor, Anxiety, Arthralgia, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-03-02
End date: 2001-03-02
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: unk unk, once
Indication: Renal Mass
Start date: 2004-03-29
End date: 2004-03-29
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Back Pain
Prohance
Indication: Imaging Procedure
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-02-22
End date: 2006-02-22
Multihance
Indication: Imaging Procedure
Other drugs received by patient: Warfarin Sodium; Bextra; Celebrex; Prilosec; Dynacirc; Testosterone; Vitamin B12 NOS; Ibuprofen; Flomax; Water Purified; Lortab; Viagra; NTP; Hydrochlorothiazide; Dovonex; Avapro; Prevacid; Vitamin B6; Aspirin
Possible Prohance side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11
Patient: 31 year old female, weighing 59.8 kg (131.6 pounds)
Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Joint Stiffness, Myalgia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, Muscular Weakness, DRY Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Stress, Skin Tightness, Finger Deformity, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy
Drug(s) suspected as cause:
Omniscan
Dosage: unk
Indication: Angiogram
Start date: 2003-01-10
End date: 2003-01-10
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-22
End date: 2003-09-22
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Optimark
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging Brain
Multihance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2007-01-18
End date: 2007-01-18
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Dilantin; Amlodipine; Prednisone; Plendil; Aspirin; Cardizem; Lamictal; Vitamin K TAB; Pravastatin; Metoprolol Tartrate; Labetalol HCL; Methadone HCL; Clonidine; Promethazine; Vicodin; Ibuprofen; Renagel; Cardura; Coumadin; Elavil; Enoxaparin; Lidocaine; Amiodarone HCL; Norvasc; Diazepam; Lovenox; Accupril; Phenytoin; Morphine; Heparin; Depakote
Possible Prohance side effects in 45 year old male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: 45 year old male, weighing 88.3 kg (194.4 pounds)
Reactions: Transplant Failure, Muscle Atrophy, Contusion, Hyperkalaemia, Unresponsive To Stimuli, Clostridium Difficile Colitis, Treatment Noncompliance, Balance Disorder, Oedema Peripheral, Blood Pressure Inadequately Controlled, Muscle Spasms, Ventricular Extrasystoles, Back Pain, Pneumonia, Cellulitis, Pain in Extremity, Renal Cancer, General Physical Health Deterioration, Lumbar Radiculopathy, Nephrogenic Systemic Fibrosis, Haemodialysis, Emotional Distress, Major Depression, Cholecystectomy, Mobility Decreased, Pain, Pallor, Pericardial Excision, Fall, Myalgia, Injury, Myocardial Infarction, Gouty Arthritis, Muscular Weakness, Rash, Discomfort, Anxiety, Sepsis, Gait Disturbance, Cardiac Arrest
Drug(s) suspected as cause:
Magnevist
Indication: Angiogram
Start date: 2007-02-05
End date: 2007-02-05
Omniscan
Indication: Product Used FOR Unknown Indication
Prohance
Indication: Product Used FOR Unknown Indication
Multihance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2002-11-20
End date: 2002-11-20
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Iron Supplement; Plavix; Lipitor; Nifedipine; Hydralazine HCL; Alprazolam; Procardia; Coumadin; Epogen; Immunosuppressive Agents; Restoril; Multi-Vitamin; Digoxin; Prednisone 50mg TAB; Coreg; Neoral; Heart Medication (Nos); Amiodarone HCL; Effexor; Coumadin; Prednisone 50mg TAB; Hydrocodone; Lipitor; Lasix
Possible Prohance side effects in 59 year old female
Reported by a consumer/non-health professional from United States on 2012-03-28
Patient: 59 year old female, weighing 109.0 kg (239.8 pounds)
Reactions: Pain, Quality of Life Decreased, Nephrogenic Systemic Fibrosis, Grief Reaction, Muscle Tightness, Skin Tightness, Anxiety, Emotional Distress, Fatigue, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Asthenia, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-08-24
End date: 1998-08-24
Magnevist
Optimark
Indication: Angiogram
Gadolinium IN Unspecified Drug
Start date: 1998-07-06
End date: 1998-07-06
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-08-01
End date: 2007-08-01
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2002-08-20
End date: 2002-08-20
Omniscan
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-07-07
End date: 2005-07-07
Other drugs received by patient: Epogen; Nephrocaps; Prednisone TAB; Plavix; Celebrex; Diatx; Colace; Sensipar; Zemplar; Timolol Maleate; Zocor; Percocet; Ibuprofen; Levothyroxine Sodium; Renagel; Epogen; Cilostazol; Prilosec; Iron [iron]; Mycophenolate Mofetil (Cellcept); Prograf; Zoloft; Proamatine; Flonase; Homatropine; Evista; Aspirin; Insulin; Phoslo; Evista; Loratadine; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Visipaque; Temazepam; Synthroid; Tricor; Miacalcin; Humalog; Paricalcitol; Lipitor; Restoril
Possible Prohance side effects in male
Reported by a physician from United States on 2012-03-27
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Anxiety, Emotional Distress, Major Depression, Injury, Immobile, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Gadolinium IN Unspecified Drug
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Magnevist
Indication: Asthenia
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Other drugs received by patient: Actonel; Metoprolol Succinate; Benicar; Norvasc; Hydralazine HCL; Tamsulosin HCL; Iron Sulfatethiamin Compound TAB; Potassium; Triamteren HCT; Amiodarone HCL; Dexamethasone; Omeprazole; Lyrica; Silodosin; Metformin HCL; Simvastatin; Coreg; Warfarin Sodium
Possible Prohance side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Other drugs received by patient: Coumadin; Temazepam; Procrit; Fosrenol; Minoxidil; Novolin R; Insulin [insulin]; Phoslo; Diatx; Vitamins NOS; Accupril; Lasix; Clonidine; Renagel
Possible Prohance side effects in 53 year old female
Reported by a pharmacist from United States on 2012-03-19
Patient: 53 year old female, weighing 114.7 kg (252.4 pounds)
Reactions: Pruritus, Pain, Erythema, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Injury, Pain in Extremity, Localised Oedema, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Activities of Daily Living Impaired, Skin Mass, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Xopenex; Vasotec; Demedex; Enalapril; Sensipar; Astelin; Phoslo; Vasopressin; Humulin N; Zelnorm; Ativan; Wellbutrin XL; Aspirin; Santyl; Norco; Keppra; Avandia; Allopurinol; Epogen; Aspirin; Torsemide; Neurontin; Hydrocodone Bitartrate and Acetaminophen; Synthroid; Regular Insulin; Renagel; NPH Insulin; Atrovent; Zyloprim; Mirapex; Glucotrol; Ibuprofen
Page 1 Next >>
|
